BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10335449)

  • 1. Arylamine N-acetyltransferase activity in man.
    Cascorbi I; Brockmöller J; Mrozikiewicz PM; Müller A; Roots I
    Drug Metab Rev; 1999 May; 31(2):489-502. PubMed ID: 10335449
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1).
    Bruhn C; Brockmöller J; Cascorbi I; Roots I; Borchert HH
    Biochem Pharmacol; 1999 Dec; 58(11):1759-64. PubMed ID: 10571250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.
    Roots I; Brockmöller J; Drakoulis N; Loddenkemper R
    Clin Investig; 1992; 70(3-4):307-19. PubMed ID: 1355678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of arylamine-N-acetyltransferase 2 gene is associated with the risk of atopic dermatitis.
    Makarova SI; Dodunova EM; Ivanova GG; Vavilin VA; Kaznacheeva LF; Lyakhovich VV
    Bull Exp Biol Med; 2005 Jun; 139(6):662-4. PubMed ID: 16224574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.
    Rodriguez JW; Kirlin WG; Ferguson RJ; Doll MA; Gray K; Rustan TD; Lee ME; Kemp K; Urso P; Hein DW
    Arch Toxicol; 1993; 67(7):445-52. PubMed ID: 7902079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
    Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
    Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants.
    Hickman D; Risch A; Camilleri JP; Sim E
    Pharmacogenetics; 1992 Oct; 2(5):217-26. PubMed ID: 1306121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylator genotype and Parkinson's disease.
    Nicholl DJ; Bennett P
    Lancet; 1998 Jan; 351(9096):141-2. PubMed ID: 9439519
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylator genotype and Parkinson's disease.
    Paolini M
    Lancet; 1998 Jan; 351(9096):141; author reply 142. PubMed ID: 9439518
    [No Abstract]   [Full Text] [Related]  

  • 10. N-Acetyltransferase 2 polymorphism in patients with Spanish toxic oil syndrome.
    Ladero JM
    Environ Health Perspect; 2002 Jan; 110(1):A14. PubMed ID: 11813699
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
    Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
    Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymorphism of N-acetyltransferase-2 and pathogenesis of neoplastic diseases].
    Kłodowska-Duda GA; Samelska JA; Opala GM
    Wiad Lek; 2005; 58(3-4):212-7. PubMed ID: 16119167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
    Smelt VA; Mardon HJ; Sim E
    Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease.
    Bandmann O; Vaughan J; Holmans P; Marsden CD; Wood NW
    Lancet; 1997 Oct; 350(9085):1136-9. PubMed ID: 9343502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAT2 gene polymorphism and sporadic colorectal cancer. Prevalence, tumor stage and prognosis. A preliminary study in 70 patients.
    Osian G; Procopciuc L; Vlad L
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):347-53. PubMed ID: 17205146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to bladder cancer.
    Taioli E; Raimondi S
    Lancet; 2005 Aug 20-26; 366(9486):610-2. PubMed ID: 16112283
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of studies of selected metabolic polymorphisms and cancer.
    d'Errico A; Malats N; Vineis P; Boffetta P
    IARC Sci Publ; 1999; (148):323-93. PubMed ID: 10493265
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of ethnic portraiture for predicting individual sensitivity to chemicals as exemplified by N-acetylation in cancer patients.
    Piruzjan LA; Radkevich LA; Morozova NV
    Dokl Biol Sci; 2003; 392():407-12. PubMed ID: 14650871
    [No Abstract]   [Full Text] [Related]  

  • 19. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
    Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
    Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.
    Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA
    Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.